Neuland Laboratories Limited (BOM:524558)
India · Delayed Price · Currency is INR 21,496
+104 (0.48%)
At close: Oct 1, 2026
Neuland Laboratories Market Cap
Neuland Laboratories has a market cap or net worth of 275.8 billion as of October 2, 2026. Its market cap has increased by 47.02% in one year.
Market Cap
275.80B
Enterprise Value
278.04B
Revenue
23.72B
Ranking
n/a
PE Ratio
55.40
Stock Price
21,496.30
ChartMarket Cap Chart
Since December 18, 2000, Neuland Laboratories's market cap has increased from 335.14M to 275.80B, an increase of 82,192.63%. That is a compound annual growth rate of 29.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 275.80B | 41.51% |
| Dec 31, 2025 | 194.89B | 10.65% |
| Dec 31, 2024 | 176.13B | 159.63% |
| Dec 29, 2023 | 67.84B | 216.90% |
| Dec 30, 2022 | 21.41B | 7.77% |
| Dec 31, 2021 | 19.86B | 41.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shilpa Medicare | 204.53B |
| Suven Life Sciences | 90.42B |
| Symbiotec Pharmalab | 75.61B |
| IOL Chemicals and Pharmaceuticals | 60.82B |
| Gujarat Themis Biosyn | 50.47B |
| NGL Fine-Chem | 17.97B |
| Bajaj HealthCare | 10.98B |
| Shree Ganesh Remedies | 8.81B |